332 results on '"SAINT-REMY, JEAN-MARIE"'
Search Results
2. Mechanisms of B-cell Tolerance
3. Modulation of Anti-Allergen Immune Responses by Allergen-Antibody Complexes
4. Retroviral Vectors Induce Epigenetic Chromatin Modifications and IL-10 Production in Transduced B Cells via Activation of Toll-like Receptor 2
5. A Role for Exposed Mannosylations in Presentation of Human Therapeutic Self-Proteins to CD4+ T Lymphocytes
6. Activation of human endothelial cells from specific vascular beds induces the release of a FVIII storage pool
7. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
8. Kinetics and thermodynamics of interaction of coagulation factor VIII with a pathogenic human antibody
9. Crystal Structures of Mite Allergens Der f 1 and Der p 1 Reveal Differences in Surface-Exposed Residues that May Influence Antibody Binding
10. Inhibitors to Factor VIII: Immunology
11. Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2
12. Development of a small molecule peptidomimetic affinity Ligand for efficient purification of the large protein Factor VIII
13. Inhibitors to Factor VIII-Immunology
14. Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen
15. The prevalence of proteolytic antibodies against factor VIII in hemophilia A
16. Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice
17. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease
18. Models for assessing immunogenicity and efficacy of new therapeutics for the treatment of haemophilia
19. Placental Growth Factor Contributes to Bronchial Neutrophilic Inflammation and Edema in Allergic Asthma
20. LIST OF CONTRIBUTORS
21. COAGULATION FACTOR AUTOANTIBODIES
22. Clotting Disorders
23. Contributors
24. The complement system and circulating immune complexes in respiratory diseases
25. Regulatory CD4+ T cells in allergic asthma
26. Novel approaches in immunotherapy
27. In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody
28. Immunology of Factor VIII Inhibitors
29. List of Contributors
30. Idiotypes and Anti-Idiotypes in Allergy
31. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A
32. Coagulation Factor VIII Autoantibodies
33. Natural Antibodies to Factor VIII
34. Natural Autoantibodies and Anti-Idiotypes
35. Low Molecular Weight Peptides Restore the Procoagulant Activity of Factor VIII in the Presence of the Potent Inhibitor Antibody ESH8
36. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model
37. Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor
38. Occupational asthma caused by sarsaparilla root dust
39. Neutralizing Antiidiotypic Antibodies to Factor VIII Inhibitors after Desensitization in Patients with Hemophilia A
40. Healthy Subjects Produce both Anti-Factor VIII and Specific Anti-Idiotypic Antibodies
41. Structure of a factor VIII C2 domain–immunoglobulin G4κ Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII
42. Antigenicity of putative phospholipid membrane-binding residues in factor VIII
43. Significant Reduction of Nonspecific Bronchial Reactivity in Patients with Dermatophagoides pteronyssinus-sensitive Allergic Asthma under Therapy with Allergen-Antibody Complexes
44. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
45. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor
46. Corrigendum: Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
47. Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A
48. Referee report. For: Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein [version 1; referees: 1 approved]
49. Thioreductase containing epitopes inhibit the development of type 1 diabetes in the NOD mouse model
50. Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.